We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lexicon Pharmaceuticals Inc | NASDAQ:LXRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 2.94% | 1.75 | 1.65 | 2.39 | 2.02 | 1.65 | 1.66 | 5,866,568 | 05:00:01 |
o
|
Preliminary Proxy Statement
|
o
|
Confidential, for Use of the Commission Only
|
o
|
Definitive Proxy Statement
|
|
(as permitted by Rule 14a-6(e)(2))
|
x
|
Definitive Additional Materials
|
|
|
o
|
Soliciting Material Pursuant to Rule 14a-11(c)or Rule 14a-12
|
|
|
LEXICON PHARMACEUTICALS, INC.
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
x
|
No fee required.
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
(1)
|
Title of each class of securities to which transaction applies: N/A
|
(2)
|
Aggregate number of securities to which transaction applies: N/A
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): N/A
|
(4)
|
Proposed maximum aggregate value of transaction: N/A
|
(5)
|
Total fee paid: $0
|
o
|
Fee paid previously with preliminary materials: N/A
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
(1)
|
Amount Previously Paid:
|
(2)
|
Form, Schedule or Registration Statement No.:
|
(3)
|
Filing Party:
|
(4)
|
Date Filed
|
—
BEFORE YOU VOTE
—
|
|
How to Access the Proxy Materials
|
—
HOW TO VOTE
—
|
|
Please Choose One of The Following Voting Methods
|
Vote in Person:
Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the Meeting you will need to request a ballot to vote these shares.
|
|
Vote by Internet:
To vote now by Internet, go to
www.proxyvote.com
. Have the information that is printed in the box marked by the arrow
ð
XXXX XXXX XXXX XXXX available and follow the instructions.
|
|
Vote by Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
Voting items
|
|
1.
|
Election of Directors
|
|
01) Philippe J. Amouyal
|
02) Lonnel Coats
|
03) Frank P. Palantoni
|
|
2.
|
Advisory vote to approve the compensation paid to the Company’s named executive officers.
|
3.
|
Ratification and approval of the appointment of Ernst & Young LLP as Company’s independent auditors for the fiscal year ending December 31, 2018.
|
1 Year Lexicon Pharmaceuticals Chart |
1 Month Lexicon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions